JOURNAL ONKOLOGIE – STUDIE

Establishment of a Tumor Bank for Blood Samples

Studien-Informationen Einschlusskriterien Studien-Rationale Studien-Arme Geprüfte Regime

Rekrutierend

Studienbeginn:
November 2003

Letztes Update:
23.03.2023

Wirkstoff:
-

Indikation (Clinical Trials):
Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Endocrine Gland Neoplasms

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
Medical University of Vienna

Collaborator:
-

Studienleiter

Robert Zeillinger, Prof.Dr.
Principal Investigator
Medical University Vienna, Dept. of Obstetrics & Gynaecology

Kontakt

Robert Zeillinger, Prof. Dr.
Kontakt:
Phone: +43140400
Phone (ext.): 78310
E-Mail: robert.zeillinger@meduniwien.ac.at» Kontaktdaten anzeigen

Eva Obermayr, PhD
Kontakt:
Phone: +43140400
Phone (ext.): 78270
E-Mail: eva.obermayr@muv.ac.at» Kontaktdaten anzeigen

Studienlocations
(3 von 6)

Charité University - Campus Virchow Chlinic
13353 Berlin
(Berlin)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Jalid Sehouli, Prof.Dr.
E-Mail: Jalid.Sehouli@charite.de

Ioana Braicu, Dr.
Phone: +49 30 450 564
Phone (ext.): 002
E-Mail: ioana@braicu.de» Ansprechpartner anzeigen

University Medical Center Freiburg
79106 Freiburg
(Baden-Württemberg)
GermanyAbgeschlossen» Google-Maps

University Clinic of Ruhr University Bochum
44626 Herne
(Nordrhein-Westfalen)
GermanyAbgeschlossen» Google-Maps

Innsbruck Medical University
6020 Innsbruck
AustriaAbgeschlossen» Google-Maps

University Hospitals Leuven - Department of Obstetrics and Gynaecology
3000 Leuven
BelgiumAbgeschlossen» Google-Maps

European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology
20100 Milan
ItalyZurückgezogen» Google-Maps

Alle anzeigen

Studien-Informationen

Detailed Description:

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to

translational research. The relevance of "translational oncology" will only increase in the

future -"From bench to bedside" - the swift implementation of new science research results in

clinical studies in order to expedite progress in clinical cancer therapy for the benefit of

the patient.

Its almost a matter of course in the medical science today to collect biological samples

together with clinical information thereby creating the foundation for future excellent

fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a tissue bank -

see EK 260/2003) and isolates of tumor patients and healthy people as controls. The

biological samples, the clinical date together with prospective experimental date constitute

the entity of the tumor bank. The content of the tumor bank can provide essential material

for current and future research (e.g. analyses of prognostic or predictive tumor markers;

genetically analysis (polymorphism, mutation, hypermethylation; verification and

characterisation of disseminated tumor cells).

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Male/Female

- Age 18 to 90 years max.

- Just one current known malignant disease or

- Just one current inflammatory disease

Exclusion Criteria:

- Inflammatory disease and malignant disease

- multiple malignancies

- multiple diseases

- underage

Studien-Rationale

Primary outcome:

1. Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls. (Time Frame - 14 years)

Studien-Arme

Malignant tumors
Patients who have one of the Neoplasms stated above under "conditions". Blood samples will be taken.
Benign controls
Patients with a benign tumor or an inflammatory disease - to be matched by age and affected organ with a patient with a malignant disease. Blood samples will be taken.
Healthy controls
People/patients who have no known disease at time of blood sampling or are admitted to the hospital for minor interventions and have no inflammatory disease. Blood samples will be taken.

Geprüfte Regime

Blood collection:
Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.

Quelle: ClinicalTrials.gov

Sie können folgenden Inhalt einem Kollegen empfehlen:

"Establishment of a Tumor Bank for Blood Samples"

Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.

Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!